Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Grant from the Andrew W Mellon Foundation provides significant boost for graduate and postdoctoral studies in the Humanities
2013-05-19

20 May 2013

The Andrew W Mellon Foundation has made an award of US $500 000 [c. ZAR 4.85 million] over three years to support graduate and postdoctoral studies in the Humanities at the University of the Free State (UFS).

The award will underwrite 20 postgraduate studentships and postdoctoral fellowships, as well as annual postgraduate skills training workshops and a research seminar programme, amongst other initiatives. Already underway following national and international advertisement, the programme has attracted highly qualified young scholars from South Africa, Botswana, Zambia and Zimbabwe, as well as from the United Kingdom and the United States. While their fields of study include history, politics, anthropology and development studies, most of the research projects have an African focus and a marked historical dimension.

Postdoctoral fellows and postgraduate students alike are associates of, or are registered in, the Centre for Africa Studies. Several of them, have already published articles in international refereed journals. Chapters in books, edited collections and single-authored monographs are all in the pipeline.

“The application to the Mellon Foundation was made in the context of UFS' strategic plan and the priority given to the importance of fostering and consolidating postgraduate and postdoctoral research. Together with other funding, this grant gives the university the opportunity to develop graduate studies in the Humanities in such a way that it surpasses many South African universities and approaches that of the best universities in the country,” says Prof Ian Phimister, Senior UFS Research Professor.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept